The Valley Desk

NCT05375084 · Interventional trial

SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation

Overall registry status Terminated

Phase 1

Conditions Non Small Cell Lung Cancer, Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov